SEC Form 4
Orthofix Medical Inc. (OFIX) insider trading
In the 12 months to Oct 26, 2026, 3 OFIX insiders reported open-market sales of $5.7M across 6 filings; 4 insiders bought $6.8M.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $5.7M
- 6 filings · 3 insiders
- Open-market purchases
- $6.8M
- 5 filings
- Pre-arranged sales (10b5-1)
- 2 of 6
- $2.8K of $5.7M sold (0%)
Who traded OFIX, and when
- Purchase
- Sale
- Sale, pre-arranged (10b5-1)
OFIX daily close from Oct 27, 2025 to Oct 26, 2026, between $8.64 and $16.20, last $9.76. 6 sale and 5 purchase filings by 6 insiders, marked at their filing dates. Alexis P. Michas, 10% owner: sold $3.6M and bought $2.7M across 3 filings, first filed May 29, 2026, last Sep 23, 2026. Arnaud Ajdler, 10% owner: bought $4.0M across 2 filings, first filed Feb 26, 2026, last May 7, 2026. John A. Bartholdson, 10% owner: sold $2.1M across 2 filings, first filed Aug 18, 2026, last Sep 22, 2026. Vickie L. Capps, Director: bought $62.3K across 1 filing, first filed Mar 10, 2026, last Mar 10, 2026. John B. Henneman III, Director: bought $61.3K across 1 filing, first filed May 8, 2026, last May 8, 2026. Patrick Fisher, President, Global Limb Recon: sold $2.8K across 2 filings, first filed Sep 3, 2026, last Oct 5, 2026.
Largest mark · tap a row for others
Alexis P. Michas · 10% owner
Purchase $2,732,097
310,000 shares at $8.81 avg
Filed Sep 23, 2026 · traded Sep 18
Close on filing date $9.18
Alexis P. Michas · 10% owner
10% owner
$3.6M sold$2.7M boughtArnaud Ajdler · 10% owner
10% owner
$4.0M boughtJohn A. Bartholdson · 10% owner
10% owner
$2.1M soldVickie L. Capps · Director
Director
$62.3K boughtJohn B. Henneman III · Director
Director
$61.3K boughtPatrick Fisher · President, Global Limb Recon
President, Global Limb Recon
$2.8K soldOpen-market trades
11 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Alexis P. Michas | 10% owner | $3.6M | $2.7M | 3 | — | |
| Arnaud Ajdler | 10% owner | — | $4.0M | 2 | — | |
| John A. Bartholdson | 10% owner | $2.1M | — | 2 | — | |
| Vickie L. Capps | Director | — | $62.3K | 1 | — | |
| John B. Henneman III | Director | — | $61.3K | 1 | — | |
| Patrick Fisher | President, Global Limb Recon | $2.8K | — | 2 | 100% of sales |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Patrick Fisher President, Global Limb Recon | SalePre-arranged (10b5-1) | 150 | $9.44 | $1.4K | 50,919 | |
traded | Alexis P. Michas 10% owner | Purchase | 310,000 | $8.81 | $2.7M | 3,771,216 | |
traded | Alexis P. Michas 10% owner | Sale | 120,000 | $8.74 | $1.0M | 3,581,216 | |
traded | John A. Bartholdson 10% owner | Sale | 190,000 | $8.86 | $1.7M | 3,771,216 | |
traded | Patrick Fisher President, Global Limb Recon | SalePre-arranged (10b5-1) | 150 | $9.39 | $1.4K | 51,069 | |
traded | John A. Bartholdson 10% owner | Sale | 39,500 | $10.20 | $402.7K | 84,926 | |
traded | Alexis P. Michas 10% owner | Sale | 242,000 | $10.70 | $2.6M | 3,461,216 | |
traded | John B. Henneman III Director | Purchase | 5,000 | $12.26 | $61.3K | 90,809 | |
traded | Arnaud Ajdler 10% owner | Purchase | 184,896 | $12.08 | $2.2M | Multiple accounts | |
traded | Vickie L. Capps Director | Purchase | 5,000 | $12.46 | $62.3K | 27,585 | |
traded | Arnaud Ajdler 10% owner | Purchase | 137,858 | $12.59 | $1.7M | Multiple accounts |
GET /stocks/filings/vX/form-4?tickers=OFIX&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"OFIX"
],
"issuer_cik": "0000884624",
"owner_cik": "0001677842",
"accession_number": "0001193125-26-414164",
"form_type": "4",
"filing_date": "2026-10-05",
"period_of_report": "2026-10-01",
"issuer_name": "Orthofix Medical Inc.",
"issuer_trading_symbol": "OFIX",
"owner_name": "Fisher Patrick",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "President, Global Limb Recon",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-10-01",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 150,
"transaction_price_per_share": 9.44,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 50919,
"transaction_value": 1416,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026."
},
{
"id": "F2",
"description": "Includes 36,028 previously reported restricted stock units."
}
]
},
{
"tickers": [
"OFIX"
],
"issuer_cik": "0000884624",
"owner_cik": "0001044005",
"accession_number": "0001794034-26-000007",
"form_type": "4/A",
"filing_date": "2026-09-23",
"period_of_report": "2026-09-18",
"issuer_name": "Orthofix Medical Inc.",
"issuer_trading_symbol": "OFIX",
"owner_name": "MICHAS ALEXIS P",
"is_director": false,
"is_officer": false,
"is_ten_percent_owner": true,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock, $0.10 par value per share",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-21",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 190000,
"transaction_price_per_share": 8.8599,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 3771216,
"transaction_value": 1683381,
"date_of_original_submission": "2026-09-22",
"not_subject_to_section_16": false,
"direct_or_indirect": "I",
"nature_of_ownership": "By: Juniper Targeted Opportunity Fund, L.P.",
"footnotes": [
{
"id": "F2",
"description": "Represents the weighted average per share price with a range from $8.63 and $8.98. The reporting person undertakes to provide details of the trades to the Issuer or the Securities and Exchange Commission upon request."
},
{
"id": "F3",
"description": "As the investment manager of Juniper Targeted Opportunity Fund, L.P. (Juniper Targeted Opportunity Fund\"), Juniper Investment Company may be deemed to beneficially own the securities held by the Juniper Targeted Opportunity Fund, Juniper Investment Company disclaims beneficial ownership of all interests reported herein except to the extent of its pecuniary interest therein. John A. Bartholdson and Alexis P. Michas serve as the managing members of Juniper Investment Company and the general partner of Juniper Targeted Opportunity Fund, and as a result, Messrs. Bartholdson and Michas share voting and dispositive power over such shares with Juniper Investment Company. Messrs. Bartholdson and Michas disclaim beneficial ownership of the holdings of Juniper Targeted Opportunity Fund reflected herein except to the extent of their pecuniary interest therein."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 36 records
- Tax withholding (sold to cover)21 records
- Grants and awards15 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
- Counted once
- When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.
Frequently asked questions
Has Orthofix Medical Inc.'s CEO sold stock?
No. Massimo Calafiore (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is OFIX’s insider data?
These are OFIX Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track OFIX insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for OFIX every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.